| Stage | SIRI | % of rev | OXY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.2B | 100.00% | $8.1B | 100.00% | OXY ×3.75 |
| Gross profit | $1.1B | 52.30% | $6.1B | 76.17% | OXY +23.9pp |
| Operating income | $479M | 22.25% | $3.8B | 47.20% | OXY +25.0pp |
| Pre-tax income | $416M | 19.32% | $3.9B | 48.54% | OXY +29.2pp |
| Net income | $317M | 14.72% | $3.0B | 37.15% | OXY +22.4pp |
| Stage | SIRI | OXY | Gap · A − B |
|---|---|---|---|
| Revenue | $2.2B100.00% | $8.1B100.00% | OXY ×3.75 |
| Gross profit | 52.30%$1.1B | 76.17%$6.1B | OXY +23.9pp |
| Operating income | 22.25%$479M | 47.20%$3.8B | OXY +25.0pp |
| Pre-tax income | 19.32%$416M | 48.54%$3.9B | OXY +29.2pp |
| Net income |
| 14.72%$317M |
| 37.15%$3.0B |
| OXY +22.4pp |
No shared counterparties.